Obesity For obesity, semaglutide is approved for people with a body mass index (BMI) of 30 or more, or a BMI of 27 or more with at least one weight-related health condition, such as high blood pressure or type 2 diabetes
MGC026, which carries the TOPI inhibitor/exatecan payload SYNtecan E, was shown to have potent antitumor activity in B7H3+ patient-derived xenograft models of prostate cancer, and is currently undergoing a phase I clinical trial in patients with advanced solid tumors, including CRPC (NCT06242470) 108,109
Maintaining a healthy diet, regular exercise, and occasional follow-up treatments will help preserve your results long-term
Lip Licking and Repeated Irritation: Frequent lip licking dries the lips instead of moisturising them
Many patients appreciate that the injections take the emotional struggle out of eating by regulating hunger naturally, allowing them to focus more on healthy living without constant willpower battles